Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression

To determine whether the variability in cytochrome P(450) (CYP)3A4 metabolic function is exhibited at both transcription and translation levels and to examine the population distribution of CYP3A4 enzyme kinetics, protein, and mRNA. Enzyme kinetics of testosterone 6beta-hydroxylation, immunoblot CYP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 2002-08, Vol.58 (5), p.357-365
Hauptverfasser: SY, Sherwin K. B, CIACCIA, Antonio, WEI LI, ROBERTS, Eve A, OKEY, Allan, KALOW, Werner, TANG, Bing-Kou
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 365
container_issue 5
container_start_page 357
container_title European journal of clinical pharmacology
container_volume 58
creator SY, Sherwin K. B
CIACCIA, Antonio
WEI LI
ROBERTS, Eve A
OKEY, Allan
KALOW, Werner
TANG, Bing-Kou
description To determine whether the variability in cytochrome P(450) (CYP)3A4 metabolic function is exhibited at both transcription and translation levels and to examine the population distribution of CYP3A4 enzyme kinetics, protein, and mRNA. Enzyme kinetics of testosterone 6beta-hydroxylation, immunoblot CYP3A4 protein, and CYP3A4 mRNA were determined in a microsomal bank of human livers. The distribution of these determinations was analyzed using cumulative distribution (probit) plots and normality test variable (NTV) to detect deviation from normality. Mean hepatic CYP3A4 protein and relative CYP3A4 mRNA were 35+/-23 pmol/mg and 79+/-59 (CYP3A4/beta-actin), respectively. Kinetic parameter estimates of testosterone 6beta-hydroxylation were 611+/-684 pmol/mg/min for maximum rate of the reaction (V(max)) and 206+/-48 micro M for the Michaelis constant (K(m)). The CYP3A4 gene expression and its activity exhibited a relatively high degree of interindividual variability. Furthermore, significant correlation between CYP3A4 protein and V(max) of testosterone 6beta-hydroxylation (r=0.82, P
doi_str_mv 10.1007/s00228-002-0487-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71999297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>820048891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-19e70566aa9279d9bc6e6568bfab66c2148a19d1bbd80bb7c6158835081c811d3</originalsourceid><addsrcrecordid>eNpdkctuFDEQRS0EIkPgA9ggCwlWaSj3w4_laMQjUngIwYKV5barJw7d9sTujhI-gm_GyQyKxKZKqjr3lq1LyHMGbxiAeJsB6lpWpVbQSlGpB2TF2qauGLTsIVkBNKziSsAReZLzBQDrFDSPyRGrmew6Divy51N0OPqwpXGg58tkAj3HnZm9pZufX5t1SzH8vpmQ_vIByzSf0F2KM_pwQk1wdPr2eU19cN6aGTN1eOWLOAY6pDjRMW6rENNkRup8npPvl7ulD__ctxiQ4vUuYc5l85Q8GsyY8dmhH5Mf799933yszr58ON2szyrb1jBXTKGAjnNjVC2UU73lyDsu-8H0nNuatdIw5VjfOwl9LyxnnZRNB5JZyZhrjsnrvW_5zOWCedaTzxbH0QSMS9aCKaVqJQr48j_wIi4plLfpcqUVinMoENtDNsWcEw56l_xk0o1moG-T0vukdKn6NimtiubFwXjpJ3T3ikM0BXh1AEy2ZhySCdbne66RXHRN1_wFck6bDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214479660</pqid></control><display><type>article</type><title>Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>SY, Sherwin K. B ; CIACCIA, Antonio ; WEI LI ; ROBERTS, Eve A ; OKEY, Allan ; KALOW, Werner ; TANG, Bing-Kou</creator><creatorcontrib>SY, Sherwin K. B ; CIACCIA, Antonio ; WEI LI ; ROBERTS, Eve A ; OKEY, Allan ; KALOW, Werner ; TANG, Bing-Kou</creatorcontrib><description>To determine whether the variability in cytochrome P(450) (CYP)3A4 metabolic function is exhibited at both transcription and translation levels and to examine the population distribution of CYP3A4 enzyme kinetics, protein, and mRNA. Enzyme kinetics of testosterone 6beta-hydroxylation, immunoblot CYP3A4 protein, and CYP3A4 mRNA were determined in a microsomal bank of human livers. The distribution of these determinations was analyzed using cumulative distribution (probit) plots and normality test variable (NTV) to detect deviation from normality. Mean hepatic CYP3A4 protein and relative CYP3A4 mRNA were 35+/-23 pmol/mg and 79+/-59 (CYP3A4/beta-actin), respectively. Kinetic parameter estimates of testosterone 6beta-hydroxylation were 611+/-684 pmol/mg/min for maximum rate of the reaction (V(max)) and 206+/-48 micro M for the Michaelis constant (K(m)). The CYP3A4 gene expression and its activity exhibited a relatively high degree of interindividual variability. Furthermore, significant correlation between CYP3A4 protein and V(max) of testosterone 6beta-hydroxylation (r=0.82, P&lt;0.001) as well as CYP3A4 protein and its mRNA (r=0.52, P&lt;0.01) was observed. Cumulative distribution plots and histograms for the CYP3A4 protein, its mRNA, and maximum testosterone 6beta-hydroxylation exhibited evidences of deviation from log-normal distribution. The minimum NTV value for the distribution of CYP3A4 protein corresponding to the inflection point in the probit occurred at approximately 10% cumulative frequency. The percentage of low CYP3A4 protein phenotype was consistent for CYP3A4 activity and its mRNA. In contrast, the distribution of K(m) of testosterone 6beta-hydroxylation does not show evidence of bimodality. The distribution of CYP3A4 metabolic function, protein, and mRNA is non-normal and may represent a regulatory polymorphism in hepatic CYP3A4 gene expression. In contrast, assessment of the possibility of a structural variant of CYP3A4 through evaluation of the standard deviation relative to the mean kinetic constant value suggests that structural mutation of CYP3A4 may not be a major factor affecting interindividual variation in CYP3A4 metabolic function.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/s00228-002-0487-9</identifier><identifier>PMID: 12185560</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adolescent ; Biological and medical sciences ; Child ; Child, Preschool ; Cytochrome P-450 CYP3A ; Cytochrome P-450 Enzyme System - genetics ; Cytochrome P-450 Enzyme System - metabolism ; Data Interpretation, Statistical ; Female ; Gene Expression ; General pharmacology ; Humans ; Infant ; Kinetics ; Liver - enzymology ; Liver - metabolism ; Male ; Medical sciences ; Middle Aged ; Models, Biological ; Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions ; Pharmacology. Drug treatments ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - metabolism ; Testosterone - metabolism</subject><ispartof>European journal of clinical pharmacology, 2002-08, Vol.58 (5), p.357-365</ispartof><rights>2002 INIST-CNRS</rights><rights>Springer-Verlag 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-19e70566aa9279d9bc6e6568bfab66c2148a19d1bbd80bb7c6158835081c811d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13867535$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12185560$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SY, Sherwin K. B</creatorcontrib><creatorcontrib>CIACCIA, Antonio</creatorcontrib><creatorcontrib>WEI LI</creatorcontrib><creatorcontrib>ROBERTS, Eve A</creatorcontrib><creatorcontrib>OKEY, Allan</creatorcontrib><creatorcontrib>KALOW, Werner</creatorcontrib><creatorcontrib>TANG, Bing-Kou</creatorcontrib><title>Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><description>To determine whether the variability in cytochrome P(450) (CYP)3A4 metabolic function is exhibited at both transcription and translation levels and to examine the population distribution of CYP3A4 enzyme kinetics, protein, and mRNA. Enzyme kinetics of testosterone 6beta-hydroxylation, immunoblot CYP3A4 protein, and CYP3A4 mRNA were determined in a microsomal bank of human livers. The distribution of these determinations was analyzed using cumulative distribution (probit) plots and normality test variable (NTV) to detect deviation from normality. Mean hepatic CYP3A4 protein and relative CYP3A4 mRNA were 35+/-23 pmol/mg and 79+/-59 (CYP3A4/beta-actin), respectively. Kinetic parameter estimates of testosterone 6beta-hydroxylation were 611+/-684 pmol/mg/min for maximum rate of the reaction (V(max)) and 206+/-48 micro M for the Michaelis constant (K(m)). The CYP3A4 gene expression and its activity exhibited a relatively high degree of interindividual variability. Furthermore, significant correlation between CYP3A4 protein and V(max) of testosterone 6beta-hydroxylation (r=0.82, P&lt;0.001) as well as CYP3A4 protein and its mRNA (r=0.52, P&lt;0.01) was observed. Cumulative distribution plots and histograms for the CYP3A4 protein, its mRNA, and maximum testosterone 6beta-hydroxylation exhibited evidences of deviation from log-normal distribution. The minimum NTV value for the distribution of CYP3A4 protein corresponding to the inflection point in the probit occurred at approximately 10% cumulative frequency. The percentage of low CYP3A4 protein phenotype was consistent for CYP3A4 activity and its mRNA. In contrast, the distribution of K(m) of testosterone 6beta-hydroxylation does not show evidence of bimodality. The distribution of CYP3A4 metabolic function, protein, and mRNA is non-normal and may represent a regulatory polymorphism in hepatic CYP3A4 gene expression. In contrast, assessment of the possibility of a structural variant of CYP3A4 through evaluation of the standard deviation relative to the mean kinetic constant value suggests that structural mutation of CYP3A4 may not be a major factor affecting interindividual variation in CYP3A4 metabolic function.</description><subject>Adolescent</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cytochrome P-450 CYP3A</subject><subject>Cytochrome P-450 Enzyme System - genetics</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Data Interpretation, Statistical</subject><subject>Female</subject><subject>Gene Expression</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Infant</subject><subject>Kinetics</subject><subject>Liver - enzymology</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</subject><subject>Pharmacology. Drug treatments</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - metabolism</subject><subject>Testosterone - metabolism</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkctuFDEQRS0EIkPgA9ggCwlWaSj3w4_laMQjUngIwYKV5barJw7d9sTujhI-gm_GyQyKxKZKqjr3lq1LyHMGbxiAeJsB6lpWpVbQSlGpB2TF2qauGLTsIVkBNKziSsAReZLzBQDrFDSPyRGrmew6Divy51N0OPqwpXGg58tkAj3HnZm9pZufX5t1SzH8vpmQ_vIByzSf0F2KM_pwQk1wdPr2eU19cN6aGTN1eOWLOAY6pDjRMW6rENNkRup8npPvl7ulD__ctxiQ4vUuYc5l85Q8GsyY8dmhH5Mf799933yszr58ON2szyrb1jBXTKGAjnNjVC2UU73lyDsu-8H0nNuatdIw5VjfOwl9LyxnnZRNB5JZyZhrjsnrvW_5zOWCedaTzxbH0QSMS9aCKaVqJQr48j_wIi4plLfpcqUVinMoENtDNsWcEw56l_xk0o1moG-T0vukdKn6NimtiubFwXjpJ3T3ikM0BXh1AEy2ZhySCdbne66RXHRN1_wFck6bDg</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>SY, Sherwin K. B</creator><creator>CIACCIA, Antonio</creator><creator>WEI LI</creator><creator>ROBERTS, Eve A</creator><creator>OKEY, Allan</creator><creator>KALOW, Werner</creator><creator>TANG, Bing-Kou</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression</title><author>SY, Sherwin K. B ; CIACCIA, Antonio ; WEI LI ; ROBERTS, Eve A ; OKEY, Allan ; KALOW, Werner ; TANG, Bing-Kou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-19e70566aa9279d9bc6e6568bfab66c2148a19d1bbd80bb7c6158835081c811d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cytochrome P-450 CYP3A</topic><topic>Cytochrome P-450 Enzyme System - genetics</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Data Interpretation, Statistical</topic><topic>Female</topic><topic>Gene Expression</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Infant</topic><topic>Kinetics</topic><topic>Liver - enzymology</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions</topic><topic>Pharmacology. Drug treatments</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - metabolism</topic><topic>Testosterone - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SY, Sherwin K. B</creatorcontrib><creatorcontrib>CIACCIA, Antonio</creatorcontrib><creatorcontrib>WEI LI</creatorcontrib><creatorcontrib>ROBERTS, Eve A</creatorcontrib><creatorcontrib>OKEY, Allan</creatorcontrib><creatorcontrib>KALOW, Werner</creatorcontrib><creatorcontrib>TANG, Bing-Kou</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SY, Sherwin K. B</au><au>CIACCIA, Antonio</au><au>WEI LI</au><au>ROBERTS, Eve A</au><au>OKEY, Allan</au><au>KALOW, Werner</au><au>TANG, Bing-Kou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression</atitle><jtitle>European journal of clinical pharmacology</jtitle><addtitle>Eur J Clin Pharmacol</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>58</volume><issue>5</issue><spage>357</spage><epage>365</epage><pages>357-365</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>To determine whether the variability in cytochrome P(450) (CYP)3A4 metabolic function is exhibited at both transcription and translation levels and to examine the population distribution of CYP3A4 enzyme kinetics, protein, and mRNA. Enzyme kinetics of testosterone 6beta-hydroxylation, immunoblot CYP3A4 protein, and CYP3A4 mRNA were determined in a microsomal bank of human livers. The distribution of these determinations was analyzed using cumulative distribution (probit) plots and normality test variable (NTV) to detect deviation from normality. Mean hepatic CYP3A4 protein and relative CYP3A4 mRNA were 35+/-23 pmol/mg and 79+/-59 (CYP3A4/beta-actin), respectively. Kinetic parameter estimates of testosterone 6beta-hydroxylation were 611+/-684 pmol/mg/min for maximum rate of the reaction (V(max)) and 206+/-48 micro M for the Michaelis constant (K(m)). The CYP3A4 gene expression and its activity exhibited a relatively high degree of interindividual variability. Furthermore, significant correlation between CYP3A4 protein and V(max) of testosterone 6beta-hydroxylation (r=0.82, P&lt;0.001) as well as CYP3A4 protein and its mRNA (r=0.52, P&lt;0.01) was observed. Cumulative distribution plots and histograms for the CYP3A4 protein, its mRNA, and maximum testosterone 6beta-hydroxylation exhibited evidences of deviation from log-normal distribution. The minimum NTV value for the distribution of CYP3A4 protein corresponding to the inflection point in the probit occurred at approximately 10% cumulative frequency. The percentage of low CYP3A4 protein phenotype was consistent for CYP3A4 activity and its mRNA. In contrast, the distribution of K(m) of testosterone 6beta-hydroxylation does not show evidence of bimodality. The distribution of CYP3A4 metabolic function, protein, and mRNA is non-normal and may represent a regulatory polymorphism in hepatic CYP3A4 gene expression. In contrast, assessment of the possibility of a structural variant of CYP3A4 through evaluation of the standard deviation relative to the mean kinetic constant value suggests that structural mutation of CYP3A4 may not be a major factor affecting interindividual variation in CYP3A4 metabolic function.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>12185560</pmid><doi>10.1007/s00228-002-0487-9</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 2002-08, Vol.58 (5), p.357-365
issn 0031-6970
1432-1041
language eng
recordid cdi_proquest_miscellaneous_71999297
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adolescent
Biological and medical sciences
Child
Child, Preschool
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System - genetics
Cytochrome P-450 Enzyme System - metabolism
Data Interpretation, Statistical
Female
Gene Expression
General pharmacology
Humans
Infant
Kinetics
Liver - enzymology
Liver - metabolism
Male
Medical sciences
Middle Aged
Models, Biological
Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions
Pharmacology. Drug treatments
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - metabolism
Testosterone - metabolism
title Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T20%3A13%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modeling%20of%20human%20hepatic%20CYP3A4%20enzyme%20kinetics,%20protein,%20and%20mRNA%20indicates%20deviation%20from%20log-normal%20distribution%20in%20CYP3A4%20gene%20expression&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=SY,%20Sherwin%20K.%20B&rft.date=2002-08-01&rft.volume=58&rft.issue=5&rft.spage=357&rft.epage=365&rft.pages=357-365&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/s00228-002-0487-9&rft_dat=%3Cproquest_cross%3E820048891%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214479660&rft_id=info:pmid/12185560&rfr_iscdi=true